Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA1

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Rizzo, Kyle ; Horwich-Scholefield, Sam ; Epson, Erin
• Description:
  We analyzed antimicrobial susceptibility test results reported in healthcare-associated infections by California hospitals during 2014-2017. Approximately 3.2% of Enterobacteriaceae reported in healthcare-associated infections were resistant to carbapenems and 26.9% were resistant to cephalosporins. The proportion of cephalosporin-resistant Escherichia coli increased 7% (risk ratio 1.07, 95% CI 1.04-1.11) per year during 2014-2017.
• Subjects:
  Beta-Lactam Resistance Carbapenems Cephalosporins Cross Infection Dispatch Enterobacteriaceae Enterobacteriaceae Infections Geography, Medical Humans Microbial Sensitivity Tests
• Source:
  Emerg Infect Dis. 25(7):1389-1393
• Pubmed ID:
  31211678
• Pubmed Central ID:
  PMC6590759
• Document Type:
  Journal Article
• Place as Subject:
  California
• Location:
  North America
• Volume:
  25
• Issue:
  7
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:bd72663f2eedd198a7e990e6a13ff6b3e6242cd3004d1ba44160af78b0821905
• Download URL:
  https://stacks.cdc.gov/view/cdc/79636/cdc_79636_DS1.pdf
• File Type:
  [PDF - 1011.35 KB ]